The novel coronavirus responsible for COVID-19 could cause no more than common cold-like coughs and sniffles within the next decade, according to a study.
The research, published in the journal Viruses, makes this likely prediction based on mathematical models that incorporate lessons learned from the current pandemic on how our body's immunity changes over time.
"This shows a possible future that has not yet been fully addressed," said Fred Adler, a professor of mathematics and biological sciences at the University of Utah in the US.
"Over the next decade, the severity of COVID-19 may decrease as populations collectively develop immunity," Adler said.
The study suggests that changes in the disease could be driven by adaptations of our immune response rather than by changes in the virus itself.
Although the SARS-CoV-2 virus is the best-known member of the family, other seasonal coronaviruses circulate in the human population, and they are less dangerous.
The researchers noted that some evidence indicates that one of these cold-causing relatives might have once been severe, giving rise to the "Russian flu" pandemic in the late 19th century.
The parallels led the scientists to wonder whether the severity of SARS-CoV-2 could similarly lessen over time.
They built mathematical models incorporating evidence on the body's immune response to SARS-CoV-2.
Analysing several scenarios and their versions set up a situation where an increasing proportion of the population will become predisposed to mild disease over the long term.
"In the beginning of the pandemic, no one had seen the virus before. Our immune system was not prepared," Adler explained.
The models show that as more adults become partially immune, whether through prior infection or vaccination, severe infections all but disappear over the next decade, the researchers said.
Eventually, the only people who will be exposed to the virus for the first time will be children who are naturally less prone to severe disease, they said.
"The novel approach here is to recognise the competition taking place between mild and severe COVID-19 infections and ask which type will get to persist in the long run," said Alexander Beams, study first author and graduate student at University of Utah.
"We have shown that mild infections will win, as long as they train our immune systems to fight against severe infections," Beams said.
However, the researchers noted that the models do not account for every potential influence on disease trajectory.
For instance, if new virus variants overcome partial immunity, COVID-19 could take a turn for the worse, they said.
The team also noted that these predictions will hold up only if the key assumptions of the models hold up.
"Our next step is comparing our model predictions with the most current disease data to assess which way the pandemic is going as it is happening," Adler added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)